At the Winter Term Passing Out Parade at OTA Gaya on March 7, 2026, Lieutenant General Dhiraj Seth highlighted the importance of adaptability in modern warfare, influenced by emerging technologies and ...

President Donald Trump plans to attend the dignified transfer for the six U.S. soldiers killed in the Middle East. On Saturday afternoon, Trump will join their mourning families at Delaware's ...

One difference between the new and original proposal is the ability for soldiers to reach backward and forward across 72 hours to use meal entitlements.

III Armored Corps and Fort Hood marked a milestone in Army food service modernization Feb. 18 with the official grand opening of 42 ...

The EA-37B is meant to disrupt enemy communications, playing havoc on their command and control and shattering their kill chains.

A rare ceremony marked three major career milestones for one U.S. Army officer as Maj. Robert January relinquished command, received a promotion to ...

Cayman’s soldiers are in line to get a purpose-built headquarters to be used as a joint services training centre, as officials also announced a change of command. Major General Mark Lancaster, the ...

Magic: The Gathering is a great game, but there’s no denying that Commander has become its most popular format - and Wizards has released a mountain of preconstructed decks for players who want to ...

The American Depositary Shares ("ADS") of the United Kingdom-based biotech Compass Pathways plc (CMPS) are soaring today, after management announced its psychedelic drug candidate COMP006 had met the ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price up 30% and teeing up talks about filing for ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...

Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical Officer Guy Goodwin. By providing 26 weeks’ worth of such data instead of the ...